Romgase Sakamula

Perivascular immune organization and spatial architecture are associated with immunotherapy response in non-small cell lung cancer

Clinical responses to immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC) remain highly heterogeneous and PD-L1 expression alone has limited predictive performance. Emerging evidence suggests that therapeutic response depends not only on immune cell abundanc...